Digitalization in chemicals and chemical distribution is the monetarization of data to significantly cut costs („Operational Excellence“) and to capture additional profitable growth areas (“New Business Models”).
Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International